Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

30.20SEK
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
30.20kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
718,463
52-wk High
38.37kr
52-wk Low
25.25kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 473.00 473.00 473.00 --
Year Ending Dec-18 1 1,652.00 1,652.00 1,652.00 --
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 --
Earnings (per share)
Quarter Ending Dec-18 1 0.25 0.25 0.25 --
Year Ending Dec-18 1 4.81 4.81 4.81 --
Year Ending Dec-19 1 2.08 2.08 2.08 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 7.87 119.85 32.14
P/E High - Last 5 Yrs. 194.36 284.29 46.82
P/E Low - Last 5 Yrs. 17.52 95.75 24.71
Beta 0.89 0.63 0.87
Price to Sales (TTM) 4.59 109.82 6.55
Price to Book (MRQ) 1.42 13.72 4.00
Price to Tangible Book (MRQ) -- 20.21 6.10
Price to Cash Flow (TTM) 7.84 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 0.89 0.35 1.68
Dividend Yield - 5 Year Avg 0.54 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) 0.00 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 243.56 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 144.34 91.25 6.56
Sales - 5 Yr. Growth Rate 81.73 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 1,985.36 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 129.60 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate 82.46 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 0.64 5.52 2.99
LT Debt to Equity (MRQ) 54.47 15.33 11.31
Total Debt to Equity (MRQ) 54.47 18.80 14.15
Interest Coverage (TTM) 3.25 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 56.69 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) 32.72 -- --
EBITD - 5 Yr. Avg 2.63 -164.07 16.13
Operating Margin (TTM) 22.88 -618.88 3.36
Operating Margin - 5 Yr. Avg. -4.09 -178.92 11.28
Pre-Tax Margin (TTM) 12.75 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -10.07 -181.48 11.54
Net Profit Margin (TTM) 48.64 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -4.30 -179.91 7.83
Effective Tax Rate (TTM) -281.57 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 14,154,000 24,741,437 725,680,242
Net Income/Employee (TTM) 6,884,463 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.26 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 12.74 0.35 9.83
Return on Assets - 5 Yr. Avg. -1.07 3.11 10.94
Return on Investment (TTM) 15.02 1.96 12.83
Return on Investment - 5 Yr. Avg. -1.46 2.91 14.05
Return on Equity (TTM) 23.35 1.12 14.95
Return on Equity - 5 Yr. Avg. -2.49 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % 89.37 179.68 81.73
EPS (TTM) % -87.84 -- --
Dividend % 13.26 -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.51 -3.10 99 59
13 Week 0.16 -4.11 99 76
26 Week 1.39 -6.04 99 56
52 Week -10.86 -12.26 99 83
YTD 0.18 -4.57 99 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.08%
# of Holders: 23
Total Shares Held: 19,848,950
3 Mo. Net Change: 5,799,929
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 12
# Reduced Positions: 2
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.